Skip to main content
Signal8

Huang Alice Shih-hou

SEC insider (Form 3/4/5 filer). CIK 0001842618. Director at Regulus Therapeutics Inc. (RGLS). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SAN DIEGO, CA.

Companies Huang Alice Shih-hou has filed insider reports for

  • Regulus Therapeutics Inc. (RGLS): Director
Huang Alice Shih-hou profile photo

Huang Alice Shih-hou

CIK: 0001842618

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Regulus Therapeutics Inc. logo
RGLS

Regulus Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jun 25, 2025
    Tender Offer
    Direct
    5.2K shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jun 25, 2025
    Disposition
    Direct
    57.3K shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jun 25, 2025
    Tender Offer
    Indirect
    27.4K shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Jun 25, 2025
    Disposition
    Indirect
    57.3K shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Apr 30, 2025
    Award
    Direct
    62.5K shares-
  • Regulus Therapeutics Inc. logo
    RGLS

    Regulus Therapeutics Inc.

    Apr 30, 2025
    Award
    Indirect
    62.5K shares-

1-6 of 6